The 2011 Congress
proceedings were published in a Leukemia Supplement dedicated to COSTEM together with the May issue of Leukemia.
ABOUT THE JOURNAL
Leukemia Supplements covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Leukemia Supplements aims at publishing good, solid, innovative science applied to 80% translational research and 20% pure science. All data that may lead to targeted therapy in a biologically relevant and leukemia specific fashion are eagerly sought after.